Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: Rationale for pharmacodynamic separation

Christopher M. Mahaffey, Angela M. Davies, Primo N Lara, Brandi Pryde, William Holland, Philip Mack, Paul H. Gumerlock, David R Gandara

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: Rationale for pharmacodynamic separation'. Together they form a unique fingerprint.

Medicine & Life Sciences